Journal
MOLECULAR AND CELLULAR ENDOCRINOLOGY
Volume 384, Issue 1-2, Pages 12-22Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.mce.2013.12.014
Keywords
CREB; COX-2; Prostaglandin; PP1/2A; Adipocytes; PKA
Categories
Funding
- Ministry of Education, Culture, Sports, Science and Technology of japan and Technology of japan (MEXT) [21570151, 25460079, 23116516]
- Japan Foundation for Applied Enzymology
- Takeda Science Foundation
- Naito Foundation
- Research Foundation for Pharmaceutical Sciences
- Daiwa Securities Health Foundation
- Grants-in-Aid for Scientific Research [25460079] Funding Source: KAKEN
Ask authors/readers for more resources
We elucidated the molecular mechanism of prostaglandin (PG) E-2- and PGF(2 alpha)-mediated suppression of the early phase of adipogenesis through enhanced COX-2 expression in 3T3-L1 cells. 3-lsobutyl-1-methylxanthine, an inhibitor of phosphodiesterase which catalyzes the conversion of cAMP to AMP, enhanced the activity of protein kinase A (PKA). Dibutyryl cAMP activated PICA and enhanced the phosphorylation of cAMP response element (CRE)-binding protein (CREB). The ability of CREB binding to the CRE of the COX-2 promoter was elevated for enhancement of the expression of the COX-2 gene. CREB siRNA suppressed the expression of the COX-2 gene. Furthermore, okadaic acid, a protein phosphatase (PP) 1/2A inhibitor, suppressed the progression of adipogenesis by preventing PP1/2A-mediated suppression of CREB-dependent COX-2 expression, thus resulting in increased production of anti-adipogenic PGE(2) and PGF(2 alpha). These results indicate that CREB-dependent expression of COX-2 for the production of anti-adipogenic PGs is critical for the regulation of the early phase of adipogenesis. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available